AlphaFold predicted structure
TNFRSF13B · O14836

Mean pLDDT
62.5/ 100
Low
293 residues
Confidence breakdown
- Very high(≥ 90)13%
- Confident(70–90)23%
- Low(50–70)23%
- Very low(< 50)41%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
TNF receptor superfamily member 13B
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
COVID-19 research
BOTH monoallelic and biallelic, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BOTH monoallelic and biallelic, autosomal or pseudoautosomalPrimary immunodeficiency or monogenic inflammatory bowel disease
BOTH monoallelic and biallelic, autosomal or pseudoautosomalimmunodeficiency, common variable, 2
immunoglobulin A deficiency 2
common variable immunodeficiency
plasma cell myeloma
monoclonal gammopathy
immunodeficiency, common variable, 1
recurrent infections associated with rare immunoglobulin isotypes deficiency
Paraproteinemia
amino acid metabolism disease
plasma protein metabolism disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Tumor necrosis factor receptor superfamily member 13B
Receptor for TNFSF13/APRIL and TNFSF13B/TALL1/BAFF/BLYS that binds both ligands with similar high affinity. Mediates calcineurin-dependent activation of NF-AT, as well as activation of NF-kappa-B and AP-1. Involved in the stimulation of B- and T-cell function and the regulation of humoral immunity
TNFRSF13B · O14836

Mean pLDDT
62.5/ 100
Low
293 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0